PolyPid Revenue vs. Net Income

PYPD Stock  USD 4.65  0.12  2.52%   
Based on the measurements of profitability obtained from PolyPid's financial statements, PolyPid may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in February. Profitability indicators assess PolyPid's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2019-06-30
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
0.0
 
Covid
At present, PolyPid's Book Value Per Share is projected to increase significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 2.21, whereas Operating Cash Flow Per Share is forecasted to decline to (4.49). The current year's Gross Profit is expected to grow to about (1.4 M)
For PolyPid profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PolyPid to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PolyPid utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PolyPid's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PolyPid over time as well as its relative position and ranking within its peers.
Check out Your Equity Center.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.The next projected EPS of PolyPid is estimated to be -0.33 with future projections ranging from a low of -0.5425 to a high of -0.495. PolyPid's most recent 12-month trailing earnings per share (EPS TTM) is at -2.81. Please be aware that the consensus of earnings estimates for PolyPid is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
PolyPid is projected to generate -0.33 in earnings per share on the 31st of December 2025. PolyPid earnings estimates show analyst consensus about projected PolyPid EPS (Earning Per Share). It derives the highest and the lowest estimates based on PolyPid's historical volatility. Many public companies, such as PolyPid, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing PolyPid's earnings estimates, investors can diagnose different trends across PolyPid's analyst sentiment over time as well as compare current estimates against different timeframes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.81)
Return On Assets
(0.88)
Return On Equity
(3.91)
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PolyPid Net Income vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining PolyPid's current stock value. Our valuation model uses many indicators to compare PolyPid value to that of its competitors to determine the firm's financial worth.
PolyPid is currently under evaluation in revenue category among its peers. It is regarded fourth in net income category among its peers . At present, PolyPid's Total Revenue is projected to stay steady based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value PolyPid by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

PolyPid Revenue vs. Competition

PolyPid is currently under evaluation in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 70.83 Million. PolyPid adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.

PolyPid Net Income vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

PolyPid

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
null
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

PolyPid

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(29.02 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

PolyPid Net Income Comparison

PolyPid is currently under evaluation in net income category among its peers.

PolyPid Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in PolyPid, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PolyPid will eventually generate negative long term returns. The profitability progress is the general direction of PolyPid's change in net profit over the period of time. It can combine multiple indicators of PolyPid, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-2.8 M-2.7 M
Operating Income-25.2 M-26.5 M
Income Before Tax-26.1 M-27.4 M
Total Other Income Expense Net-1.1 M-1.1 M
Net Loss-35.6 M-37.4 M
Net Loss-26.1 M-27.4 M
Income Tax Expense37.8 K35.9 K
Interest Income493.2 K331.4 K
Net Interest Income-1.1 M-1.1 M
Net Loss-26.1 M-27.4 M
Change To Netincome4.1 MM
Net Loss(5.64)(5.93)
Income Quality 0.68  0.46 
Net Income Per E B T 0.90  0.58 

PolyPid Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on PolyPid. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PolyPid position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PolyPid's important profitability drivers and their relationship over time.

PolyPid Earnings Estimation Breakdown

The calculation of PolyPid's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of PolyPid is estimated to be -0.33 with the future projection ranging from a low of -0.5425 to a high of -0.495. Please be aware that this consensus of annual earnings estimates for PolyPid is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.37
-0.54
Lowest
Expected EPS
-0.33
-0.49
Highest

PolyPid Earnings Projection Consensus

Suppose the current estimates of PolyPid's value are higher than the current market price of the PolyPid stock. In this case, investors may conclude that PolyPid is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and PolyPid's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
464.99%
-0.37
-0.33
-2.81

PolyPid Earnings per Share Projection vs Actual

Actual Earning per Share of PolyPid refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering PolyPid predict the company's earnings will be in the future. The higher the earnings per share of PolyPid, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

PolyPid Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as PolyPid, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of PolyPid should always be considered in relation to other companies to make a more educated investment decision.

PolyPid Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact PolyPid's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-11-12
2025-09-30-0.52-0.370.1528 
2025-08-13
2025-06-30-0.55-0.78-0.2341 
2025-05-14
2025-03-31-0.82-0.70.1214 
2025-02-12
2024-12-31-0.88-1.07-0.1921 
2024-11-13
2024-09-30-1-1.22-0.2222 
2024-08-14
2024-06-30-1.3-1.250.05
2024-05-08
2024-03-31-1.41-1.370.04
2024-02-14
2023-12-31-4.29-3.840.4510 
2023-11-08
2023-09-30-4.43-3.41.0323 
2023-08-09
2023-06-30-13.32-10.82.5218 
2023-05-10
2023-03-31-4.8-8.4-3.675 
2023-02-08
2022-12-31-12.36-9.62.7622 
2022-11-09
2022-09-30-16.22-14.41.8211 
2022-08-10
2022-06-30-20.1-18.31.8
2022-05-11
2022-03-31-18.92-18.90.02
2022-02-09
2021-12-31-16.64-21.3-4.6628 
2021-11-10
2021-09-30-18.83-15.92.9315 
2021-08-11
2021-06-30-15.75-16.8-1.05
2021-05-12
2021-03-31-15-14.10.9
2021-02-10
2020-12-31-15.23-12.32.9319 
2020-11-11
2020-09-30-12.2-10.51.713 
2020-08-19
2020-06-30-6.9-191.1-184.22669 
2020-06-29
2020-03-31-12.6-0.32512.27597 
2018-03-14
2017-12-310-3.23-3.23
2017-12-20
2017-09-300-1.28-1.28

Use PolyPid in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PolyPid position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PolyPid will appreciate offsetting losses from the drop in the long position's value.

PolyPid Pair Trading

PolyPid Pair Trading Analysis

The ability to find closely correlated positions to PolyPid could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PolyPid when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PolyPid - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PolyPid to buy it.
The correlation of PolyPid is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PolyPid moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PolyPid moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PolyPid can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your PolyPid position

In addition to having PolyPid in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Giant Impact Thematic Idea Now

Giant Impact
Giant Impact Theme
An experimental equal-weighted decomposition of large high potential stocks based on Macroaxis scoring framework. The Giant Impact theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Giant Impact Theme or any other thematic opportunities.
View All  Next Launch
When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:
Check out Your Equity Center.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
To fully project PolyPid's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of PolyPid at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include PolyPid's income statement, its balance sheet, and the statement of cash flows.
Potential PolyPid investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although PolyPid investors may work on each financial statement separately, they are all related. The changes in PolyPid's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on PolyPid's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.